Sign up to save your podcasts
Or
Share Emerging Roles for Immunotherapy in HER2+ Breast Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Emerging Roles for Immunotherapy in HER2+ Breast Cancer
Guest: Sara Tolaney MD, MPH
What do we know now about the potential safety and tolerability of administering T-DM1 with pembrolizumab to patients with HER2+ breast cancer? Breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School Dr. Sara Tolaney explains these findings from her study that was presented at the 2020 ASCO Annual Meeting.
View all episodes
By ReachMD
4.4
1414 ratings
Guest: Sara Tolaney MD, MPH
What do we know now about the potential safety and tolerability of administering T-DM1 with pembrolizumab to patients with HER2+ breast cancer? Breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School Dr. Sara Tolaney explains these findings from her study that was presented at the 2020 ASCO Annual Meeting.
More shows like Advances in Women's Health
View all
This American Life
90,949 Listeners
The Green Room: A Podcast from Obstetrics & Gynecology
60 Listeners
Medical Industry Feature
1 Listeners
SexMed
3 Listeners
Partners in Practice
3 Listeners
Second Opinion LIVE!
0 Listeners
Medical Breakthroughs from Penn Medicine
6 Listeners
GI Insights
18 Listeners
Conference Coverage
0 Listeners
AFP: American Family Physician Podcast
707 Listeners
Frankly Speaking About Family Medicine
253 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Up First from NPR
56,277 Listeners
Dr. Chapa’s Clinical Pearls.
433 Listeners
As a Woman
1,092 Listeners
Consider This from NPR
6,070 Listeners
Fertility and Sterility On Air
32 Listeners
Thinking About Ob/Gyn
40 Listeners
The Headlines
492 Listeners